PGIM Jennison Health Sciences Fund- Class R PJHRX

Morningstar Medalist Rating
  • NAV / 1-Day Return$35.71  /  −1.49%
  • Fund Size$1.5B
  • Adjusted Expense Ratio1.480%
  • Net Expense Ratio1.480%
  • Fee Level: DistributionLow
  • Share Class TypeRetirement, Small
  • Morningstar CategoryHealth
  • Equity Style Box (Funds)Large Blend
  • Minimum Initial Investment$0
  • Investment StatusOpen
  • TTM Yield0.00%
  • Turnover Ratio81%

Morningstar’s Analysis PJHRX

Will PJHRX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

Experienced hands guide this innovation-focused strategy.

Associate Analyst Natalia  Arrigoni

Natalia Arrigoni

Associate Analyst

Summary

An experienced team and a thoughtful, research-driven investment approach create a compelling healthcare offering for investors willing to stomach some volatility. It earns Above Average People and Process ratings.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings PJHRX

  • Current Portfolio Date
  • Equity Holdings—
  • Bond Holdings—
  • Other Holdings—
  • % Assets in Top 10 Holdings55.0
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

20.82309M
Healthcare

UnitedHealth Group Inc

5.8787M
Healthcare

Thermo Fisher Scientific Inc

5.4381M
Healthcare

Vertex Pharmaceuticals Inc

4.2964M
Healthcare

Danaher Corp

3.5953M
Healthcare

Merck & Co Inc

3.4451M
Healthcare

CVS Health Corp

3.0846M
Healthcare

argenx SE ADR

3.0645M
Healthcare

Elevance Health Inc

2.7040M
Healthcare

Insmed Inc

2.6740M
Healthcare

Sponsor Center